Brian T. Fisher, DO, MSCE, MPH
Professor of Pediatrics (Infectious Diseases) at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Infectious Diseases
2716 South Street
Roberts Center, Room 10362
Philadelphia, PA 19146
Division of Infectious Diseases
2716 South Street
Roberts Center, Room 10362
Philadelphia, PA 19146
Office: 267-426-7110
Fax:
Fax:
Email:
fisherbria@chop.edu
fisherbria@chop.edu
Publications
Education:
B.S. (Biology)
University of Notre Dame, 1995.
M.P.H. (Epidemiology)
University of Illinois at Chicago, 1998.
D.O. (Osteopathic Medicine)
Midwestern University-Chicago College of Osteopathic Medicine, 2002.
M.S.C.E. (Epidemiology and Biostatistics)
University of Pennsylvania, 2009.
B.S. (Biology)
University of Notre Dame, 1995.
M.P.H. (Epidemiology)
University of Illinois at Chicago, 1998.
D.O. (Osteopathic Medicine)
Midwestern University-Chicago College of Osteopathic Medicine, 2002.
M.S.C.E. (Epidemiology and Biostatistics)
University of Pennsylvania, 2009.
Links
Search PubMed for articles
Profile of current research activity within the Pediatric IDEAS Research Group
Permanent linkSearch PubMed for articles
Profile of current research activity within the Pediatric IDEAS Research Group
Description of CCEB Expertise
Dr. Fisher is a pharmacoepidemiologist with particular interest in optimizing the diagnosis, prevention and management of opportunistic infections in immunocompromised hosts. He currently serves as the Chair of the Infectious Disease Committee of the Children’s Oncology Group and co-Director of the International Pediatric Fungal Network. In these positions he helps design and perform large multicenter observational studies and randomized controlled trials in immunocompromised patient populations, specifically in children with leukemia and those undergoing hematopoietic stem cell transplantation.Selected Publications
Ladas EJ, Collier W, Park H, Auletta JJ, Dvorak CC, August A, Esbenshade AJ, Bhatia M, Fisher BT, Levine JE, Pollock BH, Uhlemann AC, Verneris MR, Walters M, Yu L, Nieder M: A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633). Transplant Cell Ther 31(7): 452.e1-452.e12, Jul 2025.Blumenstock JA, Faerber JA, Menon M, Lawler R, Downes KJ, Kratz E, Erickson K, Haltzman-Cassenti B, Yildirim I, Hussaini L, Elmontser M, Sederdahl BK, Hahn A, Thomson J, Newland J, Terrill C, Bradley J, Zachariah P, Younus M, Mo J, Wible M, Tawadrous M, Fisher BT: Leveraging real-world Data from administrative claims and medical records to inform safety and effectiveness of piperacillin-tazobactam in the Management of Pediatric Hospital Acquired Pneumonia. Am J Epdemiol 194(5): 1426-35, May 2025.
Grasty MA, L'Etoile N, Nitsche LJ, Takeda M, Fisher BT, Drant S, Mavroudis CD: Aortic Rupture in a Pediatric Patient With Influenza. World J Pediatr Congenit Heart Surg 16(1): 130-32, Jan 2025.
Bucayu RFT, Boge CLK, Yildirim I, Avilés-Robles M, Vora SB, Berman DM, Sharma TS, Sung L, Castagnola E, Palazzi DL, Danziger-Isakov L, Yin DE, Roilides E, Maron G, Tribble AC, Soler-Palacin P, López-Medina E, Romero J, Belani K, Arrieta AC, Carlesse F, Nolt D, Halasa N, Dulek D, Rajan S, Muller WJ, Ardura MI, Pong A, Gonzalez BE, Salvatore CM, Huppler AR, Aftandilian C, Abzug MJ, Chakrabarti A, Green M, Lutsar I, Knackstedt ED, Johnson SK, Steinbach WJ, Fisher BT, Wattier RL: Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network. J Pediatric Infect Dis Soc 13(12): 633-38, Dec 2024.
Segers H, Deville JG, Muller WJ, Manzanares A, Desai A, Neely M, Bordon V, Hanisch B, Lassaletta A, Fisher BT, Autmizguine J, Groll AH, Sinnar S, Croos-Dabrera R, Engelhardt M, Jones M, Kovanda LL, Arrieta AC: Safety, outcomes, and pharmacokinetics of isavuconazole as a treatment for invasive fungal diseases in pediatric patients: a non-comparative phase 2 trial. Antimicrob Agents Chemother 68(12): e0048424, Dec 2024.
Miller TP, Getz KD, Krause E, Jo YG, Charapala S, Gramatages MM, Rabin K, Scheurer ME, Wilkes JJ, Fisher BT, Aplenc R: Automated Electronic Health Record Data Extraction and Curation Using ExtractEHR. JCO Clin Cancer Inform 8: e2400100, Nov 2024.
Kitt E, Stephens-Shields AJ, Huang YV, Bitterman T, Fisher BT: Comparative Effectiveness of Perioperative Antibiotic Regimens to Prevent Surgical Site Infections in Pediatric Liver Transplant Recipients. Clin Infect Dis 79(1), Jul 2024.
Cooney LG, Sammel MD, Lee I, Clapp MA, Goldsammler M, Scott E, Bjorkman S, Fisher BT, Dokras A: The details matter: personalized prediction of live birth after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril 121(6): 1010-1019, June 2024.
Dain AS, Diorio C, Fisher BT, Hankins JS, Witmer CM, Boustany M, Burton M, Ferrolino J, Sadaf S, Ross HS, Maron G: Description of a national, multi-center registry of patients with sickle cell disease and SARS-CoV-2 infection: Data from the Pediatric COVID-19 United States Registry. Pediatr Blood Cancer 71(6): e30909, Jun 2024.
Fisher BT, Blumenstock J, Boge CLK, Shuster S, Seif AE, Green M, Michaels MG, Alexander JL, Ardura MI, Miller TP, Hijano DR, Muller WJ, Schuster JE, Green AM, Dulek DE , Kajon AE, Danziger-Isakov L : Approach for defining human adenovirus infection and disease for central review adjudication in clinical studies. Pediatric Transplantation 28(3): e14750, May 2024.